These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 3966974
1. Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU. Lee FY, Workman P. Br J Cancer; 1985 Jan; 51(1):85-91. PubMed ID: 3966974 [Abstract] [Full Text] [Related]
2. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. Lee FY, Workman P. Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803 [Abstract] [Full Text] [Related]
3. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain. Lee FY, Workman P. Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006 [Abstract] [Full Text] [Related]
4. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Hirst DG, Brown JM, Hazlehurst JL. Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845 [Abstract] [Full Text] [Related]
7. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers. Siemann DW. Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517 [Abstract] [Full Text] [Related]
8. In vivo combination of misonidazole and the chemotherapeutic agent CCNU. Siemann DW. Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287 [Abstract] [Full Text] [Related]
9. Misonidazole and benznidazole inhibit hydroxylation of CCNU by mouse liver microsomal cytochrome P-450 in vitro. Lee FY, Workman P, Cheeseman KH. Biochem Pharmacol; 1987 Apr 15; 36(8):1349-55. PubMed ID: 3593422 [Abstract] [Full Text] [Related]
10. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT, Siemann DW. Cancer Res; 1983 Oct 15; 43(10):4709-13. PubMed ID: 6883329 [Abstract] [Full Text] [Related]
11. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU. Twentyman P, Workman P. Br J Cancer; 1982 Mar 15; 45(3):447-55. PubMed ID: 7073938 [Abstract] [Full Text] [Related]
12. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards. Lee FY, Workman P. Cancer Chemother Pharmacol; 1986 Mar 15; 17(1):30-7. PubMed ID: 3698174 [Abstract] [Full Text] [Related]
13. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice. Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC. Cancer Res; 1985 Jan 15; 45(1):198-202. PubMed ID: 3965132 [Abstract] [Full Text] [Related]
14. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics. Lee FY, Workman P. Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1627-30. PubMed ID: 6237080 [Abstract] [Full Text] [Related]
15. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. Workman P, Twentyman PR. Br J Cancer; 1982 Aug 15; 46(2):249-59. PubMed ID: 7150475 [Abstract] [Full Text] [Related]
17. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine. Siemann DW. Cancer Treat Rep; 1983 Mar 15; 67(3):259-65. PubMed ID: 6831472 [Abstract] [Full Text] [Related]
18. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069. Siemann DW, Alliet K, Maddison K, Wolf K. Cancer Treat Rep; 1985 Dec 15; 69(12):1409-14. PubMed ID: 3841024 [Abstract] [Full Text] [Related]
19. Enhanced tumor responses through therapies combining CCNU, MISO and radiation. Siemann DW, Hill SA. Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1623-6. PubMed ID: 6480451 [Abstract] [Full Text] [Related]